City

Atlanta (1)

Bronx (1)

New Brunswick (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Rutgers, The State University of New Jersey (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

capecitabine (1)

laboratory biomarker analysis (1)

pembrolizumab (1)

radiation therapy (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

radiation (1)

Funder Type

Other (1)

Study Type

Interventional (1)

mismatch repair protein deficiency

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,

Recruiting

Epstein-Barr Virus Positive
+10 more

Capecitabine
+3 more

Atlanta, Georgia
+2 more

Dec 10, 2022